---
title: "This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305573660.md"
description: "Wall Street analysts initiated coverage on five stocks: Barclays rated UCTT Equal-Weight ($65 target), Wells Fargo rated DNLI Overweight ($35), Jefferies rated HAE Buy ($150), Wedbush rated MTRI Outperform ($33), and Roth Capital rated ADI Buy ($505). These initiations reflect varying bullish to neutral outlooks on the respective companies."
datetime: "2026-11-13T21:21:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305573660.md)
  - [en](https://longbridge.com/en/news/305573660.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305573660.md)
generator: "portal-rs"
---

# This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Barclays analyst Tom O’Malley initiated coverage on **Ultra Clean Holdings Inc** (NASDAQ:UCTT) with an Equal-Weight rating and announced a price target of $65. Ultra Clean closed at $46.35 on Friday. See how other analysts view this stock.
-   Wells Fargo analyst Benjamin Burnett initiated coverage on **Denali Therapeutics Inc** (NASDAQ:DNLI) with an Overweight rating and announced a price target of $35. Denali Therapeutics shares closed at $18.74 on Friday. See how other analysts view this stock.
-   Jefferies analyst Young Li initiated coverage on **Haemonetics Corporation** (NYSE:HAE) with a Buy rating and announced a price target of $150. Haemonetics closed at $122.94 on Friday. See how other analysts view this stock.
-   Wedbush analyst Laura Chico initiated coverage on **Mentari Therapeutics, Inc**. (NASDAQ:MTRI) with an Outperform rating and announced a price target of $33. Mentari Therapeutics shares closed at $18.60 on Friday. See how other analysts view this stock.
-   Roth Capital analyst Kyle Smith initiated coverage on **Analog Devices, Inc.** (NASDAQ:ADI) with a Buy rating and announced a price target of $505. Analog Devices closed at $397.97 on Friday. See how other analysts view this stock.

Considering buying ADI stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [ADI.US](https://longbridge.com/en/quote/ADI.US.md)
- [DNLI.US](https://longbridge.com/en/quote/DNLI.US.md)
- [HAE.US](https://longbridge.com/en/quote/HAE.US.md)
- [MTRI.US](https://longbridge.com/en/quote/MTRI.US.md)
- [UCTT.US](https://longbridge.com/en/quote/UCTT.US.md)
- [ADIU.US](https://longbridge.com/en/quote/ADIU.US.md)
- [UCTX.US](https://longbridge.com/en/quote/UCTX.US.md)

## Related News & Research

- [Here's How Much $1000 Invested In Analog Devices 20 Years Ago Would Be Worth Today](https://longbridge.com/en/news/305884377.md)
- [Analog Devices (ADI) Draws Fresh ETF Buying As The Undervalued Narrative Returns](https://longbridge.com/en/news/305462981.md)
- [Barclays initiates coverage of Ultra Clean Hldgs at Equal-Weight, sets price target at $65](https://longbridge.com/en/news/305463952.md)
- [Should Earnings Beat Require Action From Ultra Clean Holdings (UCTT) Investors?](https://longbridge.com/en/news/305550525.md)
- [Ultra Clean Holdings (UCTT) Could Be 59% Undervalued On Strong Q3 Results](https://longbridge.com/en/news/305577432.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**